欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
AR-42_935881-37-1_产品详情
935881-37-1
  • names:

    AR-42

  • CAS号:

    935881-37-1

    MDL Number:
  • MF(分子式): C18H20N2O3 MW(分子量): 312.36
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
AR-42
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001351-10mg 10mg 97.18% ¥ 2685.15 ¥ 2685.15 2-3天
- +
¥ 0.00
YZM001351-5mg 5mg 97.18% ¥ 1436.50 ¥ 1436.50 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名 AR-42
CAS号 935881-37-1
Inchi
InchiKey
分子式 Formula C18H20N2O3
分子量 Molecular Weight 312.36
溶解度Solubility 生物体外In Vitro:Ethanol : 50 mg/mL(160.07 mM;Need ultrasonic)
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
产品说明
IntroductionAR2 (HDAC2) is a potent, orally bioavailable panDACinhibitor (IC50=16 nM). AR2 induces growth inhibition, cellycle arrest,apoptosis, and activation of caspases/7. AR2 promotes hyperacetylation of H3, H4, and alphaubulin, and upegulation of p21. AR2 (HDAC2) shows cytotoxicity against various human cancer cell lines.
Application1
Application2
Application3
AR-42 (HDAC-42) 是一种有效的口服生物有效的泛HDAC抑制剂 (IC50=16 nM)。AR-42 (HDAC-42) 诱导生长抑制、细胞周期阻滞、凋亡和 caspases-3/7 活化。AR-42 (HDAC-42) 促进 H3、H4 和 α-微管蛋白的高乙酰化,并上调 p21。AR-42 (HDAC-42) 对多种人肿瘤细胞具有细胞毒性。AR-42 (HDAC-42) is a potent, orally bioavailable pan-HDACinhibitor (IC50=16 nM). AR-42 induces growth inhibition, cell-cycle arrest,apoptosis, and activation of caspases-3/7. AR-42 promotes hyperacetylation of H3, H4, and alpha-tubulin, and up-regulation of p21. AR-42 (HDAC-42) shows cytotoxicity against various human cancer cell lines.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Lu YS, Chou CH, Tzen KY, Gao M, ChLu YS, et al. Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e181-9.eng AL, Kulp SK, Cheng JC.Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma.Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e181-9. Epub 2012 Feb 28.
【2】.Lu Q, et al. Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. J Med Chem. 2005 Aug 25;48(17):5530-5.
【3】.Lin TY, et al. AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit. Blood. 2010 May 27;115(21):4217-25.
【4】.Zhang M, et al. AR-42 induces apoptosis in human hepatocellular carcinoma cells via HDAC5 inhibition. Oncotarget. 2016 Apr 19;7(16):22285-94.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents